This is a non-core endpoint: only basic statistics are computed.
Exclude non-diabetic causes for injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
DM_EYE_OPER_FOR_NON_DIAB_EXCLUSION
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions
DIABETES_FG
71098
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
2356
Check minimum number of events None
2356
Include endpoints None
2356
Remove individuals based on genotype QC
2276
DM_EYE_OPER_FOR_NON_DIAB_EXCLUSION
Control definitions
Control exclude
DM_EYE_OPER
Control conditions
not DIABETES_FG
Extra metadata
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Exclude non-diabetic causes for injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
based on the number of shared cases.
Broader endpoints:
- Operations, diabetic retinopathy
- Diabetic retinopathy (more control exclusions)
- Diabetic retinopathy
- Disorders of choroid and retina
- Diabetes, varying definitions
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2276 | 1060 | 1216 |
| Unadjusted prevalence (%) | 0.60 | 0.50 | 0.73 |
| Mean age at first event (years) | 72.42 | 73.07 | 71.85 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: DM_EYE_OPER_FOR_NON_DIAB_EXCLUSION – Exclude non-diabetic causes for injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Exclude non-diabetic causes for injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
↥Endpoint not on priority list, no data to show.